Hsiling Chiu

947 total citations
22 papers, 507 citations indexed

About

Hsiling Chiu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Hsiling Chiu has authored 22 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Oncology. Recurrent topics in Hsiling Chiu's work include Protein Degradation and Inhibitors (11 papers), Multiple Myeloma Research and Treatments (10 papers) and CAR-T cell therapy research (7 papers). Hsiling Chiu is often cited by papers focused on Protein Degradation and Inhibitors (11 papers), Multiple Myeloma Research and Treatments (10 papers) and CAR-T cell therapy research (7 papers). Hsiling Chiu collaborates with scholars based in United States, Switzerland and United Kingdom. Hsiling Chiu's co-authors include Shubha Govind, Jorge Morales, Anjan Thakurta, Chad C. Bjorklund, Suzana S. Couto, María Ortiz, Michael Amatangelo, Jian Kang, Maria Wang and Fadi Towfic and has published in prestigious journals such as Blood, Clinical Cancer Research and Developmental Biology.

In The Last Decade

Hsiling Chiu

21 papers receiving 502 citations

Peers

Hsiling Chiu

IMMUN

HEMAT

ONCOL

Phuong Cao Thi Ngoc Singapore

Cora Mund Germany

Sukhinder K. Sandhu United States

Lucimara Chioato Brazil

Claire Harris United Kingdom

F. J. Keith United Kingdom

Subhra Chaudhuri United States

Margs S. Brennan Australia

Kristel M. Dorighi United States

Tomas Bos Belgium

Phuong Cao Thi Ngoc Singapore

Hsiling Chiu

373 ×1.5

88 ×0.5

IMMUN

55 ×0.4

HEMAT

64 ×0.4

ONCOL

29 ×0.2

Citations per year, relative to Hsiling Chiu Hsiling Chiu (= 1×) peers Phuong Cao Thi Ngoc

Countries citing papers authored by Hsiling Chiu

Since Specialization

Citations

This map shows the geographic impact of Hsiling Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiling Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiling Chiu more than expected).

Fields of papers citing papers by Hsiling Chiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiling Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiling Chiu. The network helps show where Hsiling Chiu may publish in the future.

Co-authorship network of co-authors of Hsiling Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiling Chiu. A scholar is included among the top collaborators of Hsiling Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiling Chiu. Hsiling Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiu, Hsiling, et al.. (2025). Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method Identifying Potential Hematological Parameters for Early Diagnosis of Cervical Cancer. In Vivo. 39(2). 1042–1053. 1 indexed citations

Chiu, Hsiling, et al.. (2023). Mezigdomide Reverses T-Cell Exhaustion through Degradation of Aiolos/Ikaros and Reinvigoration of Cytokine Production Pathways. Blood. 142(Supplement 1). 335–335. 5 indexed citations

Chiu, Hsiling, et al.. (2023). Investigation of the Synergistic Combination of a Novel Celmod (CC-99282) and BET Inhibitors in Preclinical DLBCL. Blood. 142(Supplement 1). 5719–5719. 1 indexed citations

Hagner, Patrick R., Hsiling Chiu, Martino Colombo, et al.. (2022). Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. Clinical Cancer Research. 28(15). 3367–3377. 3 indexed citations

Bjorklund, Chad C., Michael Amatangelo, Hsiling Chiu, et al.. (2021). Pre-Clinical and Clinical Immunomodulatory Effects of Pomalidomide or CC-92480 in Combination with Bortezomib in Multiple Myeloma. Blood. 138(Supplement 1). 1613–1613. 6 indexed citations

Nakayama, Yumi, Hsiling Chiu, Rama Krishna Narla, et al.. (2021). Differential Effects of Iberdomide Versus Revlimid on Leukocyte Trafficking, Immune Activation and DLBCL Tumor Cell Killing. Blood. 138(Supplement 1). 718–718.

Bjorklund, Chad C., Jian Kang, Michael Amatangelo, et al.. (2019). Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN. Leukemia. 34(4). 1197–1201. 144 indexed citations

Hagner, Patrick R., Hsiling Chiu, Vivek S. Chopra, et al.. (2019). Interactome of Aiolos/Ikaros in Diffuse Large B-Cell Lymphoma (DLBCL) Reveals Novel Combination of Cereblon Modulators (CELMoD) and Histone Deacetylase (HDAC) Inhibitors. Blood. 134(Supplement_1). 306–306. 2 indexed citations

Chiu, Hsiling, Preeti Trisal, Chad C. Bjorklund, et al.. (2019). Combination lenalidomide‐rituximab immunotherapy activates anti‐tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma. British Journal of Haematology. 185(2). 240–253. 37 indexed citations

10.

Chiu, Hsiling, et al.. (2017). Combination of Lenalidomide and Rituximab (R2) Targets Immune Dysfunction in FL By Activating T and NK Cells Ex Vivo and Is Differentiated from Chemotherapy. Blood. 130. 1531–1531. 2 indexed citations

11.

Hagner, Patrick R., Hsiling Chiu, María Ortiz, et al.. (2017). Activity of lenalidomide in mantle cell lymphoma can be explained by NK cell‐mediated cytotoxicity. British Journal of Haematology. 179(3). 399–409. 39 indexed citations

12.

Bjorklund, Chad C., Jian Kang, Ling Lu, et al.. (2016). CC-220 Is a Potent Cereblon Modulating Agent That Displays Anti-Proliferative, Pro-Apoptotic and Immunomodulatory Activity on Sensitive and Resistant Multiple Myeloma Cell Lines. Blood. 128(22). 1591–1591. 12 indexed citations

13.

Hagner, Patrick R., Hsiling Chiu, Michelle F. Waldman, et al.. (2016). CC-122 Exhibits Greater Preclinical Activity in Mantle Cell Lymphoma Than Lenalidomide through a Combination of Direct Cell-Autonomous and Increased Antibody Dependent Cell-Mediated Cytotoxicity. Blood. 128(22). 4188–4188. 2 indexed citations

14.

Bjorklund, Chad C., Jian Kang, Ling Lu, et al.. (2016). CC-122 Is a Cereblon Modulating Agent That Is Active in Lenalidomide-Resistant and Lenalidomide/Dexamethasone-Double-Resistant Multiple Myeloma Pre-Clinical Models. Blood. 128(22). 1592–1592. 4 indexed citations

15.

Mehrotra, Jyoti, Haiying Wang, Hsiling Chiu, et al.. (2007). Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. The Prostate. 68(2). 152–160. 64 indexed citations

16.

Chiu, Hsiling, Jorge Morales, & Shubha Govind. (2006). Identification and immuno-electron microscopy localization of p40, a protein component of immunosuppressive virus-like particles from Leptopilina heterotoma, a virulent parasitoid wasp of Drosophila. Journal of General Virology. 87(2). 461–470. 28 indexed citations

17.

Morales, Jorge, et al.. (2005). Biogenesis, structure, and immune-suppressive effects of virus-like particles of a Drosophila parasitoid, Leptopilina victoriae. Journal of Insect Physiology. 51(2). 181–195. 55 indexed citations

18.

Chiu, Hsiling, et al.. (2005). dUbc9 negatively regulates the Toll-NF-κB pathways in larval hematopoiesis and drosomycin activation in Drosophila. Developmental Biology. 288(1). 60–72. 45 indexed citations

19.

Bodian, David, Suet Yi Leung, Hsiling Chiu, & Shubha Govind. (2003). Cytokines in Drosophila Hematopoiesis and Cellular Immunity. Progress in molecular and subcellular biology. 34. 27–46. 11 indexed citations

20.

Chiu, Hsiling & Shubha Govind. (2002). Natural infection of D. melanogaster by virulent parasitic wasps induces apoptotic depletion of hematopoietic precursors. Cell Death and Differentiation. 9(12). 1379–1381. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact